Heterogeneous nuclear ribonucleoprotein A2/B1 (
hnRNP A2/B1) has been reported to be overexpressed in
lung cancer and in other
cancers such as breast, pancreas, and liver. However, a mechanism linking
hnRNP A2/B1 overexpression and progression to
cancer has not yet been definitively established. To elucidate this mechanism, we have silenced hnRNPA2/B1
mRNA in
non-small-cell lung cancer cell lines A549, H1703, and H358. These cell lines present different levels of expression of epithelial-to-mesenchymal transition (EMT) markers such as
E-cadherin,
fibronectin, and
vimentin. Microarray expression analysis was performed to evaluate the effect of silencing
hnRNP A2/B1 in A549 cells. We identified a list of target genes, affected by silencing of
hnRNP A2/B1, that are involved in regulation of migration, proliferation, survival, and apoptosis. Silencing
hnRNP A2/B1 induced formation of cell clusters and increased proliferation. In the anchorage-independent assay, silencing
hnRNP A2/B1 increased colony formation by 794% in A549 and 174% in H1703 compared with a 25% increase in proliferation, in both cell lines, in a two-dimensional proliferation assay. Silencing
hnRNP A2/B1 decreased migration in intermediate cell line A549 and mesenchymal cell line H1703; however, no changes in proliferation were observed in epithelial cell line H358. Silencing
hnRNP A2/B1 in A549 and H1703 cells correlated with an increase of
E-cadherin expression and downregulation of the
E-cadherin inhibitors Twist1 and Snai1. These data suggest that expression of
hnRNP A2/B1 may play a role in EMT, in nonepithelial
lung cancer cell lines A549 and H1703, through the regulation of
E-cadherin expression.